These findings together suggest that ACE has beneficial effect against HFD-induced obesity and will provide valuable insights for the therapeutic potential of ACE against obesity and may aid in strategy-making for weight loss. The gene discussed is ACE; the disease is obesity due to melanocortin 4 receptor deficiency.